ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0402

Automated Detection and Quantification of Hand Joint Swelling in Rheumatoid Arthritis: Computer Vision, Deep Neural Network Models, and a Potential Biomarker for Disease Activity Monitoring

Marc Blanchard1, Jules Maglione2, Cinja Koller3, Patrick Hermann4, David Brüschweiler3, Arnd Kleyer5 and Thomas Hügle6, 1Dept. of Rheumatology, University Hospital Lausanne (CHUV) and University Lausanne, Lausanne, Switzerland, 2EPFL, Lausanne, Switzerland, 3Lausanne University Hospital, Lausanne, Switzerland, 4ATREON SA, Lausanne, Switzerland, 5University Hospital Erlangen, Erlangen, Germany, 6Dept. of Rheumatology, University Hospital Lausanne (CHUV) and University of Lausanne, Lausanne, Switzerland

Meeting: ACR Convergence 2023

Keywords: Biomarkers, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0380–0422) RA – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: We have previously shown that automated detection and processing of dorsal finger fold patterns from hand photographs can be used as a digital biomarker for joint swelling in rheumatoid arthritis.

In this study, we tested different computer vision and deep learning methods for the automated quantification of dorsal finger folds and diameter of proximal interphalangeal finger joints (PIP) in patients with rheumatoid arthritis. Additionally, the selected model aimed to evaluate the difference in PIP finger joint swelling between healthy individuals and rheumatoid arthritis patients.

Methods: We evaluated the detection and measurement of PIP joint diameter and dorsal finger fold length on hand photographs in 1783 joints of patients with rheumatoid arthritis by canny edge or ridge detection computer vision models or a newly trained convolutional neural network, respectively. The models have been trained to calculate the finger fold index (FFI, potential biomarker for joint swelling), defined as the ratio between pixel length of joint diameter and mean recognized finger folds. In an independent healthy control dataset, the FFI has been calculated to be compared with rheumatoid arthritis PIP joints.

Results: Canny edge and ridge detection were suitable models to detect dorsal finger fold patterns. The prediction of joint diameter and finger fold pixel length was best achieved in a newly trained deep neural network model, where the FFI was predictable in 93% of the images. The accuracy of correct detection of joint diameter measurement was 91%. In 1783 PIP joints of patients with rheumatoid arthritis, the mean FFI was significantly higher than in 168 healthy controls PIP joints (3.42 ± SD 1.04 and 2.15 ± SD 0.68, respectively, p-value < 0.05).

Conclusion: Finger fold index calculated by a deep neural network model seems a reliable tool for the metrical analysis and thus gradeless detection of swelling in patients with rheumatoid arthritis. Standard deviation for FFI in patients with rheumatoid arthritis was higher than in healthy patients. Therefore, further investigation by stratifying patients into different disease activity levels as well as the correlation of FFI with longitudinal changes of clinical scores on a joint-level and general disease activity is ongoing.

Supporting image 1

Figure 1: A: Keypoint detection. B: Canny edge detection. C: Metrical analysis with ridge detection. D: Newly trained deep neural network.

Supporting image 2

Figure 2: Finger Fold Index (FFI) detection and quantification, from the finger fold extraction (image recognition) to the metrical analysis and calculation (deep neural network).


Disclosures: M. Blanchard: Atreon SA, 8; J. Maglione: None; C. Koller: None; P. Hermann: ATREON SA, 4; D. Brüschweiler: None; A. Kleyer: None; T. Hügle: Atreon SA, 8, Curmed, 9, Eli Lilly, 6, Fresenius Kabi, 2, 5, Galapagos, 6, GlaxoSmithKlein(GSK), 6, Janssen, 6, Merck/MSD, 6, Pfizer, 6.

To cite this abstract in AMA style:

Blanchard M, Maglione J, Koller C, Hermann P, Brüschweiler D, Kleyer A, Hügle T. Automated Detection and Quantification of Hand Joint Swelling in Rheumatoid Arthritis: Computer Vision, Deep Neural Network Models, and a Potential Biomarker for Disease Activity Monitoring [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/automated-detection-and-quantification-of-hand-joint-swelling-in-rheumatoid-arthritis-computer-vision-deep-neural-network-models-and-a-potential-biomarker-for-disease-activity-monitoring/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/automated-detection-and-quantification-of-hand-joint-swelling-in-rheumatoid-arthritis-computer-vision-deep-neural-network-models-and-a-potential-biomarker-for-disease-activity-monitoring/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology